Iguana Healthcare Management’s Kite Pharma, Inc. KITE Stock Holding History

Iguana Healthcare Management’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-60,000	Closed	-$3.35M	–	95
2016 Q3	$3.35M	Buy	60,000 +10,000	+20%	+$557K	0.6%	51
2016 Q2	$2.5M	Hold	50,000	–	–	1.02%	33
2016 Q1	$2.3M	Buy	+50,000	New	+$2.42M	0.84%	35
2015 Q3	–	Sell	-25,000	Closed	-$1.52M	–	90
2015 Q2	$1.52M	Buy	+25,000	New	+$1.43M	0.48%	50

Other funds holding KITE

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

WCM

Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

Iguana Healthcare Management's KITE Position: Q4 2016 in Review

Iguana Healthcare Management sold out of Kite Pharma, Inc. (KITE) in Q4 2016, closing a stake of 60,000 shares — an estimated $3.35M sold.

Iguana Healthcare Management first reported a position in KITE in Q2 2015 and held it in 4 quarters. The position peaked at $3.35M in Q3 2016. 184 funds tracked by Wall St. Rank hold KITE as of Q4 2016.

Iguana Healthcare Management reported no remaining Kite Pharma, Inc. position as of Q4 2016 after selling out during the quarter.
Iguana Healthcare Management sold 60,000 Kite Pharma, Inc. shares in Q4 2016, an estimated $3.35M.
Iguana Healthcare Management first reported a position in Kite Pharma, Inc. in Q2 2015 and held it in 4 quarters.
Iguana Healthcare Management's Kite Pharma, Inc. position peaked at $3.35M in Q3 2016.
184 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2016.

Based on Iguana Healthcare Management's 13F filing for Q4 2016, filed 14 Feb 2017.